mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |